Work

LX9211 , a rising star for relieving of diabetic peripheral neuropathic pain

Year: 2024

Type: article

Abstract: In a multicenter trial, LX9211 significantly reduced pain in diabetic peripheral neuropathy (DPN) patients, with the 10 mg dose showing notable relief by the first week. Although the higher dose was less effective, side effects like dizziness and nausea were generally mild. These findings highlight the importance of exploring both pharmaceutical and natural treatments, such as flavonoids, for managing DPN.

Source: Journal of Diabetes Investigation

DOI: 10.1111/jdi.14342

Authors: Chia‐Chin Lee, Fu‐Shun Ko, Fu‐Shun Yen, Chii‐Min Hwu

Institutions: Taipei Veterans General Hospital, National Yang Ming Chiao Tung University

Language: English

Topic: Pain Mechanisms and Treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,850